A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Difelikefalin (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Cara Therapeutics
- 31 Oct 2017 According to a Cara Therapeutics media release, data from the study will be presented at the American College of Rheumatology ACR/ARHP Annual Meeting.
- 04 Oct 2017 According to a Cara Therapeutics media release, data from this trial will be presented at the Janney Montgomery Scott Osteoarthritis Pain Conference 2017.
- 31 Aug 2017 According to a Cara Therapeutics media release, data from this trial will be presented at PAINWeek 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History